March Health
March Health develops digital-twin and multi-agent AI software that helps hospitals reduce readmissions and avoidable harm.
Founded
2021March Health develops digital-twin and multi-agent AI software that helps hospitals reduce readmissions and avoidable harm.
March Health's growth case rests on hospitals' demand to contain value-based-care penalties, which its platform addresses with readmission, infection, and safety agents. Its admission to the Mayo Clinic Platform_Accelerate program in July 2025 supplies clinical validation and infrastructure support for that hospital motion.
The company labels enterprise partnerships, payer integration, and clinical studies as its stated next phase, which are plans rather than completed deployments. Signed health-system deployments and published clinical-study results would confirm this trajectory, while consumer-app stagnation would weaken it.
Source: march.health
March Health prices its consumer app as a subscription entered through a 7-day free trial and renewed yearly through Stripe checkout. The renewal price stays undisclosed, which makes the trial rather than the price point the customer's first commitment.
On the hospital side March Health competes for negotiated enterprise deals rather than self-serve adoption, with company-based pricing on request and demos as the entry step. That positioning places each deployment in hospital IT procurement cycles instead of consumer app-store pricing.
Source: march.health
March Health's two offering lines give it a dual position few AI health vendors hold: a consumer women's health base and a hospital clinical platform built on the same multi-agent architecture. The consumer app packages symptom tracking, cycle tracking, AI health agents, and shareable health reports into a mobile subscription for individual women.
The hospital platform serves a different buyer, repackaging that architecture as an EHR-integrated clinical tool for health systems with demo-led rollout and go-live inside 90 days. It sells against hospitals' value-based-care penalty exposure rather than against consumer wellness apps, which separates the two lines by customer rather than by technology.
Source: